Soluble TRAIL could enhance bone destruction acting on Rank-ligand in estrogen-independent human breast cancer cell line MDA-MB-231
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Histology,General Medicine
Reference12 articles.
1. Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin;Bouralexis;Int J Oncol,2004
2. Osteoclast differentiation and activation;Boyle;Nature,2003
3. Disabling of receptor activator of nuclear factor-B (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo;Cheng;J Biol Chem,2004
4. T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction;Colucci;Blood,2004
5. RANK ligand is a prerequisite for cancer-associated osteolytic lesions;Kitazawa;J Pathol,2002
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro;International Journal of Oncology;2016-01-15
2. SAHA/Vorinostat induces the expression of the CD137 receptor/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line;International Journal of Oncology;2012-07-13
3. Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines;Cancer Cell International;2012-06-18
4. RANK, RANKL and OPG Expression in Breast Cancer – Influence on Osseous Metastasis;Geburtshilfe und Frauenheilkunde;2012-05
5. Hypoxia induces RANK and RANKL expression by activating HIF-1α in breast cancer cells;Biochemical and Biophysical Research Communications;2011-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3